α-amino-3-hydroxy-5-methylisoxazole-4-propionate receptor autoradiography in mouse brain after single and repeated withdrawal from diazepam

European Journal of Neuroscience

Volumn 21, Issue 4, 2005, Pages 1045-1056

  Allison, C ^a   Pratt, J A ^a   Ripley, T L ^b   Stephens, D N ^b  

^a UNIVERSITY OF STRATHCLYDE   (United Kingdom)

^b UNIVERSITY OF SUSSEX   (United Kingdom)

Author keywords

Amygdala; Anxiety; Dependence; Hippocampus; Neuroadaptation; Plasticity; Thalamus

Indexed keywords

ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; AMPA RECEPTOR; DIAZEPAM; LIGAND; RECEPTOR SUBUNIT; RO 48 8587; SESAME SEED OIL; UNCLASSIFIED DRUG;

AMYGDALOID NUCLEUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY; ARTICLE; AUTORADIOGRAPHY; AVERSION; BRAIN CELL; CHRONICITY; CONTROLLED STUDY; DISEASE ASSOCIATION; DOSE TIME EFFECT RELATION; DRUG BINDING; DRUG WITHDRAWAL; EMOTION; HIPPOCAMPUS; MALE; MOTOR CORTEX; MOUSE; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; SEIZURE; SENSITIVITY ANALYSIS; THALAMUS NUCLEUS;

ANIMALS; AUTORADIOGRAPHY; BRAIN; BRAIN MAPPING; DIAZEPAM; DRUG ADMINISTRATION SCHEDULE; GABA MODULATORS; IMIDAZOLES; MALE; MICE; MICE, INBRED C57BL; PROTEIN BINDING; QUINAZOLINES; RECEPTORS, AMPA; SUBSTANCE WITHDRAWAL SYNDROME; TIME FACTORS; TISSUE DISTRIBUTION; TRITIUM;

EID: 16244400125     PISSN: 0953816X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1460-9568.2005.03902.x     Document Type: Article

References (63)

1. Albin, R.L., Makowiec, R.L., Hollingsworth, Z.R., Dure, L.S. IV, Penney, J.B. & Young, A.B. (1992) Excitatory amino acid binding sites in the basal ganglia of the rat: a quantitative autoradiography study. Neuroscience, 46 (1), 35-48.
2. Allison, C. & Pratt, J.A. (2003) Neuroadaptive processes in GABAergic and glutamatergic systems in benzodiazepine dependence. Pharmacol. Therapeut., 98, 171-195.
3. Beck, C.H.M. & Fibiger. H.C. (1995) Conditioned fear-induced changes in behaviour and in the expression of the immediate early gene c-fos: with and without diazepam pre-treatment. J. Neurosci., 15, 709-720.
4. Bruijnzeel, A.W., Stam, R., Compaan, J.C., Croiset, G., Akkermans, L.M.A., Olivier, B. & Wiegant, V.M. (1999) Long-term sensitisation of fos-responsivity in the rat central nervous system after a single stressful experience. Brain Res., 819, 15-22.
5. Cain, D.P. (1989) Excitatory neurotransmitters in kindling: excitatory amino acid, cholinergic and opiate mechanisms. Neurosci. Biobehav. Rev., 13, 169-176.
6. Clusmann, H., Stabel, J., Stephens, D.N. & Heinemann, U. (1992) Alterations in medial perforant path and mossy fibre induced field potentials in amygdala and beta-carboline (FG7142) -kindled rats. Neurosci. Lett., 146, 65-68.
7. Collins, R.C., Tearse, R.G. & Lothman, E.W. (1983) Functional anatomy of limbic seizures: focal discharges from medial entorhinal cortex in rat. Brain Res., 280, 25-40.
8. 3 receptor agonist and antagonists for alteration of aversive behaviour in the mouse. Br. J. Pharmacol., 96, 325-332.
9. Czlonkowska, A., Siemiatkowski, M. & Plaznik, A. (1997) Some behavioral effects of AMPA/kainate receptor agonist and antagonists. J. Physiol. Pharmacol., 48, 479-488.
10. Davis, M. (1992a) The role of the amygdala in fear and anxiety. Annu. Rev. Neurosci., 15, 353-375.
11. Davis, M. (1992b) The role of the amygdala in conditioned fear. In Aggleton, J.P. (Ed.). The Amygdala: Neurobiological Aspects of Emotion, Memory and Mental Dysfunction. Wiley-Liss, Inc., New York, pp. 255-305.
12. Davis, M. & Whalen, P.J. (2001) The amygdala: vigilance and emotion. Mol. Psychiat, 6, 13-34.
13. Davis, M., Rainnie, D. & Cassell, M. (1994) Neurotransmission in the rat amygdala related to fear and anxiety. Trends Neurosci., 17, 208-214.
14. Del Bel, E.A., Silveira, M.C., Graeff, F.G., Garcia-Cairasco, N. & Guimaraes, F.S. (1998) Differential expression of c-fos mRNA and Fos protein in the rat brain after restraint stress or pentylenetetrazol-induced seizures. Cell Mol. Neurobiol., 18, 339-346.
15. Dumvorth, S.J. & Stephens, D.N. (1998) Sensitisation to repeated withdrawal, in mice treated chronically with diazepam, is blocked by an NMDA receptor antagonist. Psychopharmacology, 136, 308-310.
16. Dunworth, S.J. & Stephens, D.N. (2002) Provision of cues to signal a withdrawal US prevents the US pre-exposure effect in a diazepam-withdrawal conditioned taste aversion. Psychopharmacology (Berl.), 160, 245-252.
17. Dunworth, S.J., Mead, A.N. & Stephens, D.N. (2000) Previous experience of withdrawal from chronic diazepam ameliorates the aversiveness of precipitated withdrawal and reduces withdrawal-induced c-fos expression in nucleus accumbens. Eur. J. Neurosci., 12, 1501-1508.
18. File, S.E. & Fernandes, C. (1994) Dizocilpine prevents the development of tolerance to the sedative effects of diazepam in rats. Pharmacol. Biochem. Behav., 47, 823-826.
19. File, S.E. & Fernandes, C. (1994) Dizocilpine prevents the development of tolerance to the sedative effects of diazepam in rats. Pharmacol. Biochem. Behav., 47, 823-826. Franklin, K.B.J. & Paxinos, G. (1997) The Mouse Brain in Stereotaxic Coordinates. Academic Press, London.
20. Gale, K. (1992) Subcortical structures and pathways involved in convulsive seizure generation. J. Clin. Neurophysiol., 9, 264-277.
21. Gray, J.A. (1987) The neuropsychology of anxiety. An Enquiry in to the Functions of the Septohippocampal System. Oxford Science Publications, Oxford.
22. Green, S. & Vale, A.L. (1992) Role of amygdaloid nuclei in the anxiolytic effects of benzodiazepines in rats. Behav. Pharmacol., 3, 261-264.
23. Hodges, H., Green, S. & Glenn, B. (1987) Evidence that the amygdala is involved in benzodiazepine and serotonergic effects on punished responding but not on discrimination. Psychopharmacology, 92, 491-504.
24. Izzo, E., Anta, J., Impagnatiello, F., Pesold, C., Guidotti, A. & Costa, E. (2001) Glutamic acid decarboxylase and glutamate receptor changes during tolerance and dependence to benzodiazepines. Proc. Natl Acad. Sci. U.S.A., 98, 3483-3488.
25. Karcz-Kubicha, M. & Liljequist, S. (1995) Evidence for an anxiogenic action of AMPA receptor antagonists in the plus-maze test. Eur: J. Pharmacol., 279, 171-177.
26. Kodama, M., Yamada, N., Sato, K., Kitamura, Y., Koyama, F., Sato, T., Morimoto, K. & Kuroda, S. (1999) Effects of YM90K, a selective AMPA receptor antagonist, on amygdala-kindling and long-term hippocampal potentiation in the rat. Eur. J. Pharmacol., 374, 11-19.
27. Kotlinska, J. & Liljequist, S. (1998) The putative AMPA receptor antagonist, LY326325, produces anxiolytic-like effects without altering locomotor activity in rats. Pharmacol Biochem. Behav., 60, 119-124.
28. Kraus, J.E., Yeh, G.G., Bonhaus, D.W., Nadler, J.V. & McNamara, J.O. (1994) Kindling induces the long-lasting expression of a novel population of NMDA receptors in hippocampal region CA3. J. Neurosci., 14, 196-205.
29. LeDoux, J. (1998) Fear and the brain: where have we been, and where are we going? Biol. Psychiat., 44, 1229-1238.
30. Lissin, D.V., Gomperts, S.N., Carroll, R.C., Christine, C.W., Kalman, D., Kitamura, M., Hardy, S., Nicoll, R.A., Malenka, R.C. & Von Zastrow, M. (1998) Activity differentially regulates the surface expression of synaptic AMPA and NMDA receptors. Proc. Natl Acad. Sci. U.S.A., 95, 7097-7102.
31. Lothman, E.W., Hatlelid, J.M. & Zorumski, C.F. (1985) Functional mapping of limbic seizures originating in the hippocampus: a combined 2-deoxyglucose and electrophysiologic study. Brain Res., 360, 92-100.
32. Maddock, R.J. (1999) The retrosplenial cortex and emotion; new insights from functional neuroimaging of the human brain. Trends Neurosci., 22, 310-316.
33. Mesches, M.H., Bianchin, M. & McGaugh, J.L. (1996) The effects of intraamygdala infusion of the AMPA receptor antagonist CNQX on retention performance following aversive training. Neurobiol. Learn. Mem., 66, 324-340.
34. Mody, I. & Heinemann, U. (1987) NMDA receptors of dentate gyrus granule cells participate in synaptic transmission following kindling. Nature, 326, 701-704.
35. Monaghan, D.T., Yao, D. & Cotman, C.W. (1984) Distribution of [3H]AMPA binding sites in rat brain as determined by quantitative autoradiography. Brain Res., 324, 160-164.
36. 3H]Ro48 8587 in rat brain. J. Neurochem., 71, 418-426.
37. Nadler, J.V, Thompson, M.A. & McNamara, J.O. (1994) Kindling reduces sensitivity of CA3 hippocampal pyramidal cells to competitive NMDA receptor antagonists. Neuropharmacology, 33, 147-153.
38. Namba, T., Morimoto, K., Sato, K., Yamada, N. & Kuroda, S. (1994) Antiepileptogenic and anticonvulsant effects of NBQX, a selective AMPA receptor antagonist, in the rat kindling model of epilepsy. Brain Res., 638, 36-44.
39. Nielsen, E.O., Cha, J.H., Honore, T., Penney, J.B. & Young, A.B. (1988) Thiocyanate stabilizes AMPA binding to the quisqualate receptor. Eur. J. Pharmacol., 157, 197-203.
40. 3H]α-amino- 3-hydroxy-5-methyl-4-isoxazole-propionic acid binding sites. J. Neurochem., 54, 686-695.
41. 3H]AMPA binding to glutamate receptor subpopulations in rat brain. Brain Res., 402, 243-254.
42. Pinel, J.P. & Van Oot, P.H. (1975) Generality of the kindling phenomenon: some clinical implications. Can. J. Neurol Sci., 2, 467-475.
43. Pratt, J.A. (1992) The neuroanatomical basis of anxiety. Pharmac. Ther., 55, 149-181.
44. Raichle, M. (1990) Exploring the mind with dynamic imaging. Semin. Neurosci., 2, 307-315.
45. 3H]AMPA, a structural analogue of glutamic acid. Brain Res., 309, 173-177.
46. Reiman, E.M., Raichle, M.E., Robins, E., Mintun, E., Fusselman, M.J., Fox, P.T., Price, J.L. & Hackman, K.A. (1989) Neuroanatomical correlates of a lactate-induced anxiety attack. Arch. Gen. Psychiat., 46, 493-500.
47. Scheel-Kruger, J. & Petersen, E.N. (1982) Anticonflict effects of the benzodiazepines mediated by a GABAergic mechanism in the amygdala. Eur. J. Pharmacol., 82, 115-116.
48. Shibata, H. (2000) Organisation of retrosplenial cortical projections to the laterodorsal thalamic nucleus in the rat. Neurosci. Res., 38, 303-311.
49. Soncrant, T.T., Holloway, H.W., Stipetic, M. & Rapoport, S.I. (1988) Cerebral glucose utilization in rats is not altered by hindlimb restraint or by femoral artery and vein cannulation. J. Cereb. Blood Flow Metab., 8, 720-726.
50. Stephens, D.N. (1995) A glutamatergic hypothesis of drug dependence. Behav. Pharmacol., 6, 425-446.
51. Stephens, D.N. & Dunworth, S.J. (2000) Previous experience of diazepam withdrawal prevents the formation of a withdrawal-conditioned taste aversion: test of a blocking hypothesis. Behav. Pharmacol., 11, 471-481.
52. Stephens, D.N. & Turski, L. (1993) Kindling to the benzodiazepine receptor inverse agonist FG 7142: evidence for involvement of NMDA, but not non-NMDA glutamatergic receptors. Neuropharmacology, 32, 1011-1017.
53. Steppuhn, K.G. & Turski, L. (1993) Diazepam dependence prevented by glutamate antagonists. Proc. Natl Acad. Sci., 90, 6889-6893.
54. Steppuhn, K.G., Schneider, H.H., Turski, L. & Stephens, D.N. (1993) Longterm treatment with abecamil does not induce diazepam-like dependence in mice. J. Pharmacol. Exp. Ther., 264, 1395-1400.
55. Swedberg, M.D., Jacobsen, P. & Honore, T. (1995) Anticonvulsant, anxiolytic and discriminative effects of the AMPA antagonist 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(f)quinoxaline (NBQX). J. Pharmacol. Exp. Ther., 274, 1113-1121.
56. Turski, L., Jacobsen, P., Honore, T. & Stephens, D.N. (1992) Relief of experimental spasticity and anxiolytic/anticonvulsant actions of the alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate antagonist 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline. J. Pharmacol. Exp. Ther., 260, 742-747.
57. Van Sickle, B.J. & Tietz, E.I. (2002) Selective enhancement of AMPA receptor-mediated function in hippocampal CA1 neurons from chronic benzodiazepine-treated rats. Neuropharmacology, 43, 11-27.
58. Veatch, L.M. & Gonzalez, L.P. (1999) Repeated ethanol withdrawal delays development of focal seizures in hippocampal kindling. Alc. Clin. Exp. Res., 23, 1145-1150.
59. Wang, C., Wilson, W.A. & Moore, S.D. (2001) Role of NMDA, non-NMDA and GABA receptors in signal propagation in the amygdala formation. J. Neurophysiol., 86, 1422-1429.
60. Ward, B.O. & Stephens, D.N. (1998) Sensitisation of withdrawal signs following repeated withdrawal from a benzodiazepine: Differences between measures of anxiety and seizure sensitivity. Psychopharmacology, 135, 342-352.
61. Wirtshafter, D., Asin, K.E. & Pitzer, M.R. (1994) Dopamine agonists and stress produce different patterns of Fos-like immunoreactivity in the lateral habenula. Brain Res., 633, 21-26.
62. Woods, J.H., Katz, J.L. & Winger, G. (1992) Benzodiazepines: Use, abuse and consequences. Pharmacol. Rev., 44, 151-338.
63. Yokoyama, C. & Sasaki, K. (1999) Regional expression of fos-like immunoreactivity in rat cerebral cortex after stress, restraint and intraperitoneal lipopolysaccharide. Brain Res., 816, 267-275.